Full-text record
Article abstract
A verified author-written abstract was not available in the source metadata. The journal has preserved the publication without inventing or rewriting the scholarly record.
Citation record
How to cite this article
Binni Kumari, Mohit Gupta (2025). Harnessing Computational Tools for Next-Generation Antibacterial Therapies. Procedure International Journal of Science and Technology, 2(5), 1–20. https://doi.org/10.62796/pijst.2025v2i5001
Binni Kumari, Mohit Gupta. “Harnessing Computational Tools for Next-Generation Antibacterial Therapies.” Procedure International Journal of Science and Technology, vol. 2, no. 5, 2025, pp. 1–20. https://doi.org/10.62796/pijst.2025v2i5001
Binni Kumari, Mohit Gupta. “Harnessing Computational Tools for Next-Generation Antibacterial Therapies.” Procedure International Journal of Science and Technology 2, no. 5 (2025): 1–20. https://doi.org/10.62796/pijst.2025v2i5001
Binni Kumari, Mohit Gupta (2025) ‘Harnessing Computational Tools for Next-Generation Antibacterial Therapies’, Procedure International Journal of Science and Technology, 2(5), pp. 1–20. Available at: https://doi.org/10.62796/pijst.2025v2i5001.
Binni Kumari, Mohit Gupta, “Harnessing Computational Tools for Next-Generation Antibacterial Therapies,” Procedure International Journal of Science and Technology, vol. 2, no. 5, pp. 1–20, 2025. https://doi.org/10.62796/pijst.2025v2i5001.
Binni Kumari, Mohit Gupta. Harnessing Computational Tools for Next-Generation Antibacterial Therapies. Procedure International Journal of Science and Technology. 2025;2(5):1–20. https://doi.org/10.62796/pijst.2025v2i5001.
Binni Kumari, Mohit Gupta. Harnessing Computational Tools for Next-Generation Antibacterial Therapies. Procedure International Journal of Science and Technology 2025, 2 (5), 1–20. https://doi.org/10.62796/pijst.2025v2i5001.
Record provenance
Publication history
Published31 May 2025
DOI assigned31 May 2025
Record versionVersion of Record
Research integrity
Declarations
Funding
No separate funding declaration was available in the verified source record; the journal policy applies.
Conflict of Interest
No separate conflict-of-interest declaration was available in the verified source record; the journal policy applies.
Ethical Approval
No separate ethical approval statement was available in the verified source record; the article and journal policies apply.
Data Availability
No separate data-availability statement was available in the verified source record; contact the author(s) or editorial office where appropriate.
Author Contributions
No separate author-contribution statement was available in the verified source record; authorship follows the published article record.
AI-use Declaration
No separate AI-use declaration was available in the verified source record; the journal AI-use policy applies.
Editorial record
Publisher's Note
The views, opinions and conclusions expressed in this article are those of the author(s). Publication does not imply endorsement by the journal, editorial board or publisher. Responsibility for accuracy, originality and integrity remains with the author(s). Readers should independently evaluate and verify information before application or citation.
Open-access terms
License & Copyright
Copyright © 2025 Author(s). This work is published by Procedure International Journal of Science and Technology under the Creative Commons Attribution-NonCommercial 4.0 International. Authors retain copyright and grant the journal the right of first publication.
Source record
References
Showing first 3 of 24 references.
- Chinemerem Nwobodo D, Ugwu MC, Oliseloke Anie C, et al. Antibiotic resistance: The challenges and some emerging strategies for tackling a global menace. J Clin Lab Anal. 2022;36(9):e24655. doi:10.1002/jcla.24655. https://doi.org/10.1002/jcla.24655
- World Health Organisation. Antimicrobial resistance; Fact sheet. WHO; 2021. Accessed June 20, 2022 [Google Scholar]. Source
- Cardoso MH, Orozco RQ, Rezende SB, Rodrigues G, Oshiro KGN, Cândido ES and Franco OL (2020) Computer-Aided Design of Antimicrobial Peptides: Are We Generating Effective Drug Candidates? Front. Microbiol. 10:3097. doi: 10.3389/ fmicb.2019.03097.
- Porto, W. F., Silva, O. N., and Franco, O. L. (2012). “Prediction and rational design of antimicrobial peptides,” in Protein Structure, ed. E. Faraggi (London: InTech), 377–396.
- Hiss, J. A., Hartenfeller, M., and Schneider, G. (2010). Concepts and applications of “natural computing” techniques in de novo drug and peptide design. Curr. Pharm. Des. 16, 1656–1665. doi: 10.2174/138161210791164009. https://doi.org/10.2174/138161210791164009
- Stokes, Jonathan M., et al. “A deep learning approach to antibiotic discovery.” Cell 180.4 (2020): 688-702.
- Artificial intelligence yields new antibiotic, Anne Trafton | MIT News Office Publication Date:February 20, 2020, MIT News on campus and around the world.
- Maccari, G., Di Luca, M., Nifosi, R., Cardarelli, F., Signore, G., Boccardi, C., et al. (2013). Antimicrobial peptides design by evolutionary multiobjective optimization. PLoS Comput. Biol. 9:e1003212. doi: 10.1371/journal.pcbi.1003212. https://doi.org/10.1371/journal.pcbi.1003212
- Li H, Kang WT, Zheng Y, et al. Development of xanthone derivatives as effective broad-spectrum antimicrobials: Disrupting cell wall and inhibiting DNA synthesis. Sci Adv. 2025;11(10):eadt4723. doi:10.1126/sciadv.adt4723. https://doi.org/10.1126/sciadv.adt4723
- Bax BD, Chan PF, Eggleston DS, et al. Type IIA topoisomerase inhibition by a new class of antibacterial agents. Nature. 2010;466(7309):935-940. doi:10.1038/ nature09197.
- Cardoso, Marlon H., et al. “Computer-aided design of antimicrobial peptides: are we generating effective drug candidates?.” Frontiers in microbiology 10 (2020): 3097.
- Zhang M, Lin S, Han L, et al. Safety and efficacy evaluation of halicin as an effective drug for inhibiting intestinal infections. Front Pharmacol. 2024;15:1389293. Published 2024 May 9. doi:10.3389/fphar.2024.1389293. https://doi.org/10.3389/fphar.2024.1389293
- Thompson MG, Black CC, Pavlicek RL, et al. Validation of a novel murine wound model of Acinetobacter baumannii infection. Antimicrob Agents Chemother. 2014;58(3):1332-1342. doi:10.1128/AAC.01944-13. https://doi.org/10.1128/AAC.01944-13
- Bax B. D.; Murshudov G.; Maxwell A.; Germe T. DNA topoisomerase inhibitors: trapping a DNA-cleaving machine in motion. J. Mol. Biol. 2019, 431, 3427–3449. 10.1016/j.jmb.2019.07.008. https://doi.org/10.1016/j.jmb.2019.07.008
- Bax B. D.; Chan P. F.; Eggleston D. S.; Fosberry A.; Gentry D. R.; Gorrec F.; Giordano I.; Hann.
- M. M.; Hennessy A.; Hibbs M.; Huang J.; Jones E.; Jones J.; Brown K. K.; Lewis C. J.; May E. W.; Saunders M. R.; Singh O.; Spitzfaden C. E.; Shen C.; Shillings A.; Theobald A. J.; Wohlkonig (Online).
- A.; Pearson N. D.; Gwynn M. N. Type IIA topoisomerase inhibition by a new class of antibacterial agents. Nature 2010, 466, 935–940. 10.1038/nature09197. https://doi.org/10.1038/nature09197
- Mathpal D, Masand M, Thomas A, et al. Pharmacophore modeling, docking and the integrated use of a ligandand structure-based virtual screening approach for novel DNA gyrase inhibitors: synthetic and biological evaluation studies. RSC Adv. 2021;11(55):34462-34478. Published 2021 Oct 25. doi:10.1039/d1ra05630a. https://doi.org/10.1039/d1ra05630a
- Kolariè A, Anderluh M, Minovski N. Two Decades of Successful SAR-Grounded Stories of the Novel Bacterial Topoisomerase Inhibitors (NBTIs). J Med Chem. 2020;63(11):5664-5674. doi:10.1021/acs.jmedchem.9b01738. https://doi.org/10.1021/acs.jmedchem.9b01738
- Spyrakis F, Santucci M, Maso L, et al. Virtual screening identifies broad-spectrum â-lactamase inhibitors with activity on clinically relevant serineand metallocarbapenemases. Sci Rep. 2020;10(1):12763. Published 2020 Jul 29. doi:10.1038/ s41598-020-69431-y.
- Dermawan D, Alotaiq N. Computational analysis of antimicrobial peptides targeting key receptors in infection-related cardiovascular diseases: molecular docking and dynamics insights. Sci Rep. 2025;15(1):8896. Published 2025 Mar 14. doi:10.1038/s41598-025-93683-1. https://doi.org/10.1038/s41598-025-93683-1
- Wong, Felix, et al. “Benchmarking AlphaFoldenabled molecular docking predictions for antibiotic discovery.” Molecular systems biology 18.9 (2022): e11081.
- Perryman AL, Yu W, Wang X, et al. A virtual screen discovers novel, fragmentsized inhibitors of Mycobacterium tuberculosis InhA. J Chem Inf Model. 2015;55(3):645-659. doi:10.1021/ci500672v. https://doi.org/10.1021/ci500672v
- Zhou P, Hong J. Structureand Ligand-Dynamics-Based Design of Novel Antibiotics Targeting Lipid A Enzymes LpxC and LpxH in Gram-Negative Bacteria. Acc Chem Res. 2021;54(7):16231634. doi:10.1021/ acs.accounts.0c00880.
Discover more